c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors

Alterations in the transcriptional factor c-MYC could be involved in the anti-EGFR resistance in metastatic colorectal cancer (mCRC). The c-MYC expression was evaluated in 121 RAS and BRAF wild-type mCRC before treatment with anti-EGFR+Folfiri therapy and in 33 subsequent metastases collected during...

Descripción completa

Detalles Bibliográficos
Autores principales: Strippoli, Antonia, Cocomazzi, Alessandra, Basso, Michele, Cenci, Tonia, Ricci, Riccardo, Pierconti, Francesco, Cassano, Alessandra, Fiorentino, Vincenzo, Barone, Carlo, Bria, Emilio, Ricci-Vitiani, Lucia, Tortora, Giampaolo, Larocca, Luigi Maria, Martini, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139615/
https://www.ncbi.nlm.nih.gov/pubmed/32164324
http://dx.doi.org/10.3390/cancers12030638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139615/
https://www.ncbi.nlm.nih.gov/pubmed/32164324
http://dx.doi.org/10.3390/cancers12030638

Ejemplares similares